Colorado Hospitals Participate in Breast Cancer Prevention Trial
Penrose-St. Francis Health Services, Colorado Springs,Colo., and St. Mary-Corwin Medical Center, Pueblo, Colo., participated in a clinical trial of the drug raloxifene to reduce breast cancer risk. Initial results of the Study of Tamoxifen and Raloxifene (STAR), one of the largest breast cancer prevention trials ever conducted, show that raloxifene works as well as tamoxifen in reducing breast cancer risk for postmenopausalwomen at increased risk of the disease. In the STAR trial, both drugs reduced the risk of developing invasive breast cancer by about 50 percent. For more information, contact Tanya Dantzler of Penrose-St. Francis at firstname.lastname@example.org; or Jillian Maes of St. Mary-Corwin at email@example.com.